Measuring the quality of care of diabetic patients at the Specialist Outpatient Clinics in Public Hospitals in Singapore

Annals of the Academy of Medicine Singapore

Volumn 36, Issue 12, 2007, Pages 980-986

  Toh, Matthias P H S ^a   Bee, Hoon Heng ^a   Chee, Fang Sum ^b   Jong, Michelle ^c   Siok, Bee Chionh ^d   Cheah, Jason T S ^a  

^a NATIONAL HEALTHCARE GROUP   (Singapore)

^b ALEXANDRA HOSPITAL   (Singapore)

^c TAN TOCK SENG HOSPITAL   (Singapore)

^d NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

Assessment; Indicators; Outcome; Process

Indexed keywords

CREATININE; HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; COMPUTER PROGRAM; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DATA ANALYSIS; DIABETES MELLITUS; DIABETIC PATIENT; FEMALE; GLYCEMIC CONTROL; HEALTH CARE QUALITY; HEMOGLOBIN DETERMINATION; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MEDICAL RECORD REVIEW; MEDICAL SPECIALIST; OUTCOME ASSESSMENT; OUTPATIENT CARE; OUTPATIENT DEPARTMENT; PATIENT CARE; PRIMARY MEDICAL CARE; PUBLIC HOSPITAL; QUALITATIVE ANALYSIS; RETROSPECTIVE STUDY;

EID: 39749134906     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Zimmet PZ, McCarty DJ, de Courten MP. The global epidemiology of non-insulin-dependent diabetes mellitus and the metabolic syndrome. J Diabetes Complications 1997;11:60-8.
2. Ministry of Health, Singapore. Epidemiology and Disease Control Department. National Health Survey 2004, Singapore. Singapore: Ministry of Health, 2005.
3. Diabetes Atlas Committee. Diabetes Atlas. 3rd ed. Brussels (Belgium): International Diabetes Federation, 2006.
4. Williams DR. A proposal for continuing audit of diabetes services. Home and Members of a Working Group of the Research Unit of the Royal College of Physicians and British Diabetic Association. Diabet Med 1992;9:759-64.
5. Clinical Practice Guidelines on Diabetes Mellitus. Singapore: Ministry of Health, 1999.
6. Lee WR, Lim HS, Thai AC, Chew WL, Emmanuel S, Goh LG, et al. A window on the current status of diabetes mellitus in Singapore - the Diabcare-Singapore 1998 study. Singapore Med J 2001;42:501-7.
7. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. Diabetes Prevention Program Research Group. N Engl J Med 2002;346:393-403.
8. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993;329:977-86.
9. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352:837-53. Erratum in: Lancet 1999;354:602.
10. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ 1998;317:703-13. Erratum in BMJ 1999;318:29.
11. Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40. UK Prospective Diabetes Study Group. BMJ 1998;317:720-6.
12. Goldberg RB, Mellies MJ, Sacks FM, Moye LA, Howard BV, Howard WJ, et al. Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investigators. Circulation 1998;98:2513-9.
13. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICROHOPE substudy. Heart Outcomes Prevention Evaluation Study investigators. Lancet 2000;355:253-9. Erratum in: Lancet 2000;356:860.
14. Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 1991;98(5 Suppl):766-85.
15. Litzelman DK, Slemenda CW, Langefeld CD, Hays LM, Welch MA, Bild DE, et al. Reduction of lower extremity clinical abnormalities in patients with non-insulin-dependent diabetes mellitus: A randomized, controlled trial. Ann Intern Med 1993;119:36-41.
16. Lifetime benefits and costs of intensive therapy as practiced in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group. JAMA 1996;276:1409-15. Erratum in: JAMA 1997;278:25.
17. Peters AL, Legoretta AP, Ossorio RC, Davidson MB. Quality of outpatient care provided to diabetic patients. A health maintenance organization experience. Diabetes Care 1996;19:601-6.
18. Fain JA, Melkus GD. Nurse practitioner practice patterns based on standards of medical care for patients with diabetes. Diabetes Care 1994;17:879-81.
19. Weiner JP, Parente ST, Garnick DW, Fowles J, Lawthers AG, Palmer RH. Variation in office-based quality. A claims-based profile of care provided to Medicare patients with diabetes. JAMA 1995;273:1503-8.
20. Marshall CL, Bluestein M, Chapin C, Davis T, Gersten J, Harris C, et al. Outpatient management of diabetes mellitus in five Arizona Medicare managed care plans. Am J Med Qual 1996;11:87-93.
21. Fleming BB, Greenfield S, Engelgau MM, Pogach LM, Clauser SB, Parrott MA. The Diabetes Quality Improvement Project: moving science into health policy to gain an edge on the diabetes epidemic. Diabetes Care 2001;24:1815-20. Erratum in: Diabetes Care 2002;25:249.
22. Meigs JB, Stafford RS. Cardiovascular disease prevention practices by U.S. Physicians for patients with diabetes. J Gen Intern Med 2000;15:220-8.
23. Saaddine JB, Engelgau MM, Beckles GL, Gregg EW, Thompson TJ, Narayan KM. A diabetes report card for the United States: quality of care in the 1990s. Ann Intern Med 2002;136:565-74.
24. Chin MH, Auerbach SB, Cook S, Harrison JF, Koppert J, Jin L, et al. Quality of diabetes care in community health centers. Am J Public Health 2000;90:431-4.
25. Wylie-Rosett J, Basch C, Walker EA, Zybert P, Shamoon H, Engel S, et al. Ophthalmic referral rates for patients with diabetes in primary-care clinics located in disadvantaged urban communities. J Diabetes Complications 1995;9:49-54.
26. Wylie-Rosett J, Walker EA, Shamoon H, Engel S, Basch C, Zybert P. Assessment of documented foot examinations for patients with diabetes in inner-city primary care clinics. Arch Fam Med 1995;4:46-50.
27. Miller KL, Hirsch IB. Physicians' practices in screening for the development of diabetic nephropathy and the use of glycosylated hemoglobin levels. Diabetes Care 1994;17:1495-7.
28. Mayfield JA, Rith-Najarian SJ, Acton KH, Schraer CD, Stahn RM, Johnson MH, et al. Assessment of diabetes care by medical record review. The Indian Health Service model. Diabetes Care 1994;17:918-23.
29. Chin MH, Zhang JX, Merrell K. Diabetes in the African-American Medicare population. Morbidity, quality of care, and resource utilization. Diabetes Care 1998;21:1090-5.
30. Marrero DG. Current effectiveness of diabetes health care in the U.S.: how far from the ideal? Diabetes Rev 1994;2:292-309.
31. Hiss RG, Anderson RM, Hess GE, Stepien CJ, Davis WK. Community diabetes care. A 10-year perspective. Diabetes Care 1994;17:1124-34.
32. Peterson KA. Diabetes care by primary care physicians in Minnesota and Wisconsin. J Fam Pract 1994;38:361-7.
33. Bernard AM, Anderson L, Cook CB, Phillips LS. What do internal medicine residents need to enhance their diabetes care? Diabetes Care 1999;22:661-6.
34. Raheja BS, Kapur A, Bhoraskar A, Sathe SR, Jorgensen LN, Moorthi SR, et al. DiabCare Asia - India Study: diabetes care in India - current status. J Assoc Physicians India 2001;49:717-22.
35. Chuang LM, Tsai ST, Huang BY, Tai TY; Diabcare-Asia 1998 Study Group. The status of diabetes control in Asia - a cross-sectional survey of 24,317 patients with diabetes mellitus in 1998. Diabet Med 2002;19:978-85.
36. Kleinman JC, Donahue RP, Harris MI, Finucane FF, Madans JH, Brock DB, et al. Mortality among diabetics in a national sample. Am J Epidemiol 1988;128:389-401.
37. Beckman TJ. Regular screening in type 2 diabetes. A mnemonic approach for improving compliance, detecting complications. Postgrad Med 2004;115:19-20,23-7.
38. Bakris GL. Microalbuminuria: what is it? Why is it important? What should be done about it? J Clin Hypertens (Greenwich) 2001;3:99-102.
39. McKenna K, Thompson C. Microalbuminuria: a marker to increased renal and cardiovascular risk in diabetes mellitus. Scott Med J 1997;42:99-104.